Zinc 14,23,33-tritert-butyl-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-6-carboxylic acid
C45H40N8O2Zn — CID 139261581
Data last refreshed: (MolForge compound catalog, from PubChem)
About Zinc 14,23,33-tritert-butyl-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-6-carboxylic acid
Zinc 14,23,33-tritert-butyl-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-6-carboxylic acid (PubChem CID 139261581) has the molecular formula C45H40N8O2Zn and a molecular weight of 790.26 g/mol. Its IUPAC name is zinc 14,23,33-tritert-butyl-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-6-carboxylic acid.
Molecular Properties
| Compound Name | Zinc 14,23,33-tritert-butyl-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-6-carboxylic acid |
|---|---|
| PubChem CID | 139261581 |
| Molecular Formula | C45H40N8O2Zn |
| Molecular Weight | 790.26 g/mol |
| Exact Mass | 788.26 |
| IUPAC Name | zinc 14,23,33-tritert-butyl-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(36),2,4(9),5,7,10(40),11,13(18),14,16,19,21(38),22(27),23,25,28,30,32,34-nonadecaene-6-carboxylic acid |
| SMILES | CC(C)(C)c1ccc2c3nc4nc(nc5[n-]c(nc6nc(nc([n-]3)c2c1)-c1cccc(C(C)(C)C)c1-6)c1cccc(C(C)(C)C)c51)-c1ccc(C(=O)O)cc1-4.[Zn+2] |
| InChI | InChI=1S/C45H41N8O2.Zn/c1-43(2,3)23-17-19-25-29(21-23)39-47-34(25)46-38-28-20-22(42(54)55)16-18-24(28)35(48-38)50-40-33-27(13-11-15-31(33)45(7,8)9)37(52-40)53-41-32-26(36(49-39)51-41)12-10-14-30(32)44(4,5)6;/h10-21H,1-9H3,(H2-,46,47,48,49,50,51,52,53,54,55);/q-1;+2/p-1 |
| InChIKey | VGRWFSNFYXXSOX-UHFFFAOYSA-M |
| XLogP | 9.72 |
| TPSA | 142.84 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 790.26 |
| LogP ≤ 5 | 9.72 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139261581 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.